Category: Dopamine

Home
original-work-veerpal-470x260_0.jpg

Jurors Are Left Traumatized by Some Court Cases

00Decision-Making, Dopamine, Empathy, Featured news, Health, Law and Crime, Post-Traumatic Stress Disorder, Stress, Trauma April, 19

Source: Marica Villeneuve, Trauma and Mental Health Report artist, used with permission

On November 7, 2016, the Ministry of the Attorney General of Ontario reached a settlement with a juror diagnosed with vicarious post-traumatic stress disorder. The juror served on the trial of eight-year-old Tori Stafford’s killer.

The woman, who cannot be named due to a publication ban protecting the identity of jurors in this case, received the diagnosis months after performing her civic duty. Four years ago, she was one of 12 jurors in the trial of Michael Rafferty, the man charged and convicted of kidnapping, sexually assaulting, and murdering Stafford.

While sitting on the jury during the two-month trial, the woman visited scenes of rape, saw photographic evidence of the crime, and heard eyewitness testimony from Rafferty’s girlfriend and accomplice, Terri-Lynne McClintic.

In a submission to the Ontario Court of Appeal, the juror said that, almost immediately after the trial, she lashed out at her children, suffered from depression, had flashbacks to disturbing pieces of evidence, and experienced short-term memory loss and difficulties with concentration.

Over the course of a criminal trial, jurors are often exposed to disturbing graphic evidence. And while jury members are instructed to remain unbiased and evenhanded, the process can take a toll on their mental health.

Beyond the traumatizing effects of graphic evidence, the weight of the task itself can be harmful to jurors’ wellbeing. The high-stakes decision that members have been tasked with, which includes determining the fate of someone’s life, can be psychologically taxing. This pattern of stress and anxiety is frequently observed in other high-pressure jobs that involve exposure to traumatic information and heavy responsibilities, such as social work.

Patrick Baillie, a psychologist with Alberta Health Services, and former Chair of the Mental Health Commission of Canada, says that jury members are often not mentally prepared to sit through a criminal trial:

“These are twelve citizens who don’t typically have any involvement with the system, which is why we want them to serve as jurors, being given this extraordinary task with not a whole lot of mental support.”

In addition to the responsibility of remaining impartial, jurors are not allowed to share any details related to their deliberations. To protect the integrity of the trial, members are prohibited from discussing their personal views on the evidence, witnesses, or trial process, to ensure confidential information cannot be related back to discussions that took place in the jury room. Baillie explains:

“It is illegal to disclose the deliberation of a jury to anybody. So, [you] can’t tell a spouse and family and friends… people in [your] usual support system and the mental health professionals that [you] may want to come in contact with down the road. We need to make sure that jurors are not identified and to make sure the process is pure as it can be.”

Under these circumstances, jury members are left to process the psychological and emotional effects of the trial on their own.

Barbara Legate, the lawyer representing the juror from Stafford’s case, argues:

“We ask jurors to sit through days, weeks, and sometimes months of testimony and sometimes that testimony is very, very difficult, and we ask them to keep it to themselves, not discuss it with people outside.”

Until recently, Ontario judges were responsible for deciding whether jurors should be offered counseling at the end of a trial. Jurors would then either be connected with counselors provided by the Ministry of the Attorney General or would pursue counseling on their own.

Starting in January 2017, however, Ontario initiates a new program to provide free and accessible counseling services to anyone serving on a jury. The Ontario Attorney General Yasir Naqvi says the Juror Support Program will be available for anyone serving in a criminal or civil trial, or an inquest.

Jurors will be provided with information on the program at the beginning of a trial, and then again as it finishes. They will call a designated phone number, speak to a specialist who does an assessment, and have counseling made available to them. A third party will provide and cover the costs of the counseling services, but the government still determines who that third party will be. Naqui says:

“Jurors in difficult trials do face evidence that could be quite horrific, and we’ve heard those stories. It’s only appropriate that we provide appropriate services.”

-Veerpal Bambrah, Contributing Writer, The Trauma and Mental Health Report

– Chief Editor: Robert T. Muller, The Trauma and Mental Health Report.

-Copyright Robert T. Muller

This article was originally published on Psychology Today

tl3-_-feature-1_preview-470x260.jpeg

Surprising Side Effect of Parkinson’s Drug: Creativity

00Career, Creativity, Dopamine, Featured news, Psychiatry, Psychopharmacology, Self-Control August, 18

Source: Image Credits Feature: Ingrid Hauff, Used With Permission

In 2014, Ingrid Hauff was diagnosed with Parkinson’s disease (PD), a degenerative disorder that attacks the nervous system, leading to speech impairment, loss of control over body movement, and a long list of other symptoms. Plus, there is no cure.

Struggling with the diagnosis, Hauff checked herself into a psychiatric clinic where she was introduced to art therapy. The clinic supplied her with materials, and the staff asked her to paint what she felt. She initially used painting as a way to cope with the illness.

Hauff tells the Trauma and Mental Health Report:

“Before my diagnosis, I never painted. I could never have imagined that painting would be so important to me like it is today. I paint every day. It is a great pleasure for me to paint. I forget every trouble, and I find the [disease’s] side effects are lessened.”

Painting has become more than therapy for Hauff. It’s now a fundamental part of her life, and her unique artistic style and choice of colour have helped her become a successful artist. She has even held an exhibition of her landscape paintings in Berlin.

But her story of artistic knack and creative development is, surprisingly, not a rare one for those diagnosed with PD. Some scientists are investigating whether medications, such as Levodopa and Pramipexol, prescribed to relieve PD symptoms, heighten creativity. These drugs increase the neurotransmitter dopamine, a chemical in the brain that regulates movement. Dopamine is gradually depleted as PD progresses, so boosting this neurotransmitter allows patients to retain regular movement and regain control over their bodies.

Like all medications, though, these drugs have a multitude of side effects, ranging from headaches and nausea, to tremors and hallucinations. Unlike other medications, however, one side effect stands out from the rest: uninhibited creativity.

Neurologist Rivka Inzelberg and colleagues published a study in 2014, finding that patients treated with dopaminergic drugs showed enhanced verbal and visual creativity in comparison to neurologically healthy individuals who were not on the medication. This is one of several studies where Inzelberg demonstrated that PD medications are associated with higher rates of creative capability.

But in some instances, patients claim to produce artwork to a point where they can’t restrain themselves. Eugénie Lhommée and her colleagues interviewed people with PD and published a case study on the influence of increased dopamine on creativity. In it, the patient reported:

“I transformed my home into a studio, with tables and canvases everywhere [and] started painting from morning till night. I used knives, forks, sponges […] I would gouge open tubes of paint—it was everywhere. I started painting on the walls, the furniture, even the washing machine. I would paint any surface I came across. I could not stop myself from painting and repainting every night in a trance-like state. My partner could no longer bear it. People close to me realized that I crossed some kind of line into the pathological, and, at their instigation, I was hospitalized.”

Hauff also experienced an “extreme influence” on her artwork when prescribed Pramipexol:

“I began painting for hours every night. I didn’t have any ability to stop. I lost a lot of sleep and was constantly without energy after these sessions, so I decided, together with my neurologist, to stop [Pramipexol]. I’ve been off of it since the beginning of February 2017, and now after one month [on new medication], I can declare that my feeling of control has come back.”

While these experiences can be damaging to patients and their loved ones, Hauff was able to take advantage of this unique side effect by exhibiting and selling the artwork she had produced. Her solution to the problem was to switch to a different medication. The creative boost remained, but the compelling drive disappeared. Hauff explains:

“My creativity is still there, but the ‘painting time’ is now reduced radically. I am painting only during the daytime. My opinion is that Pramipexol limits my ability to maintain self-control.”

But Hauff has no regrets about her experience with Pramipexol:

“It let me find my creativity and showed me what I can do. It showed me secret parts of my soul. It showed me what has slept in my brain and in my heart for nearly 60 years. It showed me a way to live with my Parkinson’s.”

As is the case for most individuals considering a drug therapy, people with PD have to weigh the benefits and drawbacks of medication options. But as more research on this unexpected and artistic by-product emerges, it begs the question of whether similar medications can be used to boost creativity in the future.

– Ty LeBlanc, Contributing Writer. The Trauma and Mental Health Report.

-Chief Editor: Robert T. Muller, The Trauma and Mental Health Report.

Copyright Robert T. Muller

This article was originally published on Psychology Today